VITAMIN B17 / AMYGDALIN

also known as LAETRILE 

IS THE KEY TO CANCER PREVENTION, THE NOVEL CHOICE OR ADJUNCT FOR CANCER TREATMENT!

In 1902 John Beard, a Professor of Embryology at the University of Edinburgh, suggested that malignant tumors—cancer might be cured by the effective use of ordinary enzymes (instead of the maiming surgery, poisonous Chemotherapy, or burning radiation used by the modern medical establishment).  Both Beard and his theory were ridiculed by the Scientists of that day and it wasn’t until 1938 that his work was discovered and continued by Dr. Ernst Krebs and his son, Dr. Ernst Krebs Jr.  Both of these men devoted their lives to nutritional therapy and during the 1950’s their years of research paid off, they had isolated a new vitamin they numbered B17 and gave it the name laetrile.   As the years rolled by thousands became convinced that Drs. Krebs had finally found the complete controlling substance for all cancers, a conviction that even more people share today.  Back in 1950’s the Krebs had no idea the hornet’s nest they had stirred up.

Because their discovery was derived from a natural source (the prunus amygdalis rosacea family) they were unable to patent or claim exclusive rights to the vitamin that they had isolated. The multinationals pharmaceuticals giants began to launch vicious attacks, (and have continued till today) setting unprecedented propaganda against B17 despite its effectiveness.

Laetrile is also known by its more common generic name "Amygdalin", or Vitamin B17, and found in natural foods, which contain nitriloside and has been used and studied extensively for well over 100 years.  The use of Amygdalin in the treatment of human cancer dates back at least to 1843, although the ancient Chinese are reported to have used bitter almonds containing significant quantities of it in the treatment of tumors some 3,000 years ago.  The prunus amygdalis rosacea family is particularly prevalent in the seeds of the following fruits; bitter almond, apricot, blackthorn, cherry, nectarine, peach and plum.  It is also contained in grasses, maize, sorghum, millet, cassava, linseed, apple, and many other foods that generally have been deleted from the menus of modern civilization.  The most common source of B17 is the apricot kernel and is present in about 2-3 percent levels of concentration within the seed kernel.  The exact action of Laetrile on cancer cells is still theoretical even though it has clear and obvious results.

Normal cells have a very important enzyme called rhodanese, apparently cancer cells do not possess this important enzyme, in fact they have another enzyme called beta-glucosidase, (that releases cyanide) and benzaldehyde (which poisons the cancer cells).  In cancer cells beta-glucosidase is always present in great quantity, sometimes at levels of one hundred times than that of the surrounding normal cells. The theory is that vitamin B17 is unlocked within the cancer cell then releases its poisons and only the cancer is affected.  This inactivates the cyanide and converts it into a by-product that actually becomes beneficial for the body.

How effective is Laetrile in Cancer metabolic Therapy?

Laetrile is not a magic bullet. There are a number of factors that enter into the cancer treatment complex. The type of cancer involved is an important one. Some types of cancer tend to be more sensitive than others. Laetrile is not equally effective in all types of cancers.

In their clinical investigations in Israel where they were using laetrile, Rubin and Issahary (1976) found that it was most effective against adenocarcinomas and Hodgkin’s disease. It was somewhat less effective in sarcomas and leukemia. Similar results have been achieved in Mexico, the U.S. and elsewhere (Navarro, 1957a,b; Contreras, 1982). Navarro (1955, 1957a,b) and Navarro and Lagman (1956) reported excellent results using laetrile and the enzyme chymotrypsin in a five-year study in 83 cancer patients. The types of cancers treated included adenocarinoma of the breast, stomach, lungs, tongue, larynx, nasopharynx, rectum, colon, liver, esophagus, thyroid, uterus, Hodgkin’s, lymphorcomas, fibrosarcomas, etc.

At no time did they encounter any evidence of toxicity from the use of laetrile. They obtained the following results: Twenty percent of the patients receive a decrease in the size of the tumor or complete regression. They found that most of the patients suffered much less pain except in those who had taken deep radiotherapy. Some of the patients were able to relieve the feted odor of superficial cancerous lesions by topical applications of laetrile. They were able to relieve the feted odor of internal cancers by using parenteral injections of laetrile. The appetite improved in anorexic patients with a resulting gain weight. Hypertensive cancer patients developed a reduction in blood pressure. A few patients developed a low fever. The reader should see the original articles for further details.

One of the things that they have found is that they get better tumor regression when Laetrile is used in conjunction with Vitamin A and enzymes. They conducted a laboratory study in mice working with murine adenocarcinoma and found that they got up to 89.3% tumor regression depending upon the site of the tumors (Contreras, 1982). This is one of the reasons why the Greens were using vitamin A and enzymes in Chad’s diet, but the Court made them discontinue these nutrients